Elevance Health Inc (NYSE:ELV) — Market Cap & Net Worth
Market Cap & Net Worth: Elevance Health Inc (ELV)
Elevance Health Inc (NYSE:ELV) has a market capitalization of $63.54 Billion ($63.54 Billion) as of May 2, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #416 globally and #210 in its home market, demonstrating a 7.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elevance Health Inc's stock price $372.68 by its total outstanding shares 220704667 (220.70 Million). Analyse Elevance Health Inc (ELV) cash conversion ratio to see how efficiently the company converts income to cash.
Elevance Health Inc Market Cap History: 2015 to 2026
Elevance Health Inc's market capitalization history from 2015 to 2026. Data shows growth from $27.43 Billion to $82.25 Billion (10.35% CAGR).
Index Memberships
Elevance Health Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$59.46 Trillion | 0.23% | #171 of 503 |
Weight: Elevance Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Elevance Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elevance Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.39x
Elevance Health Inc's market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.66x
Elevance Health Inc's market cap is 13.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $28.84 Billion | $84.98 Billion | $2.47 Billion | 0.34x | 11.68x |
| 2017 | $45.78 Billion | $90.04 Billion | $3.84 Billion | 0.51x | 11.91x |
| 2018 | $54.07 Billion | $92.11 Billion | $3.75 Billion | 0.59x | 14.42x |
| 2019 | $62.90 Billion | $104.21 Billion | $4.81 Billion | 0.60x | 13.09x |
| 2020 | $67.78 Billion | $121.87 Billion | $4.57 Billion | 0.56x | 14.82x |
| 2021 | $99.03 Billion | $138.64 Billion | $6.10 Billion | 0.71x | 16.22x |
| 2022 | $110.75 Billion | $156.59 Billion | $5.89 Billion | 0.71x | 18.79x |
| 2023 | $103.12 Billion | $171.34 Billion | $5.99 Billion | 0.60x | 17.22x |
| 2024 | $81.42 Billion | $176.81 Billion | $5.98 Billion | 0.46x | 13.62x |
| 2025 | $77.37 Billion | $199.12 Billion | $5.66 Billion | 0.39x | 13.66x |
Competitor Companies of ELV by Market Capitalization
Companies near Elevance Health Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Elevance Health Inc by market ranking:
- UnitedHealth Group Incorporated (NYSE:UNH): Ranked #66 globally with a market cap of $256.27 Billion USD.
- CVS Health Corp (NYSE:CVS): Ranked #242 globally with a market cap of $101.04 Billion USD.
- Humana Inc (NYSE:HUM): Ranked #1117 globally with a market cap of $22.79 Billion USD.
- Centene Corp (NYSE:CNC): Ranked #1299 globally with a market cap of $19.48 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #66 | UnitedHealth Group Incorporated | NYSE:UNH | $256.27 Billion | $368.78 |
| #242 | CVS Health Corp | NYSE:CVS | $101.04 Billion | $82.09 |
| #1117 | Humana Inc | NYSE:HUM | $22.79 Billion | $233.63 |
| #1299 | Centene Corp | NYSE:CNC | $19.48 Billion | $53.34 |
Elevance Health Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Elevance Health Inc's market cap moved from $27.43 Billion to $ 82.25 Billion, with a yearly change of 10.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $82.25 Billion | +6.31% |
| 2025 | $77.37 Billion | -4.97% |
| 2024 | $81.42 Billion | -21.04% |
| 2023 | $103.12 Billion | -6.89% |
| 2022 | $110.75 Billion | +11.83% |
| 2021 | $99.03 Billion | +46.12% |
| 2020 | $67.78 Billion | +7.74% |
| 2019 | $62.90 Billion | +16.33% |
| 2018 | $54.07 Billion | +18.11% |
| 2017 | $45.78 Billion | +58.72% |
| 2016 | $28.84 Billion | +5.15% |
| 2015 | $27.43 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Elevance Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $63.54 Billion USD |
| MoneyControl | $63.54 Billion USD |
| MarketWatch | $63.54 Billion USD |
| marketcap.company | $63.54 Billion USD |
| Reuters | $63.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more